Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

Literature DB >> 2712546

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections.

E A Piercy¹, D Barbaro, J P Luby, P A Mackowiak.

Abstract

Thirty-seven patients with methicillin-resistant Staphylococcus aureus infections and/or colonization were treated with oral ciprofloxacin (750 mg twice a day). Clinical cure or improvement of infections occurred in 91% of the patients, and bacteriologic cure occurred in 60%. Ciprofloxacin therapy suppressed methicillin-resistant S. aureus colonization in 55% of the patients. Ciprofloxacin-resistant strains emerged in 6 of the 37 patients.

Entities: Chemical Disease Species

Mesh：

Substances：
Ciprofloxacin
Methicillin

Year: 1989 PMID： 2712546 PMCID： PMC171438 DOI： 10.1128/AAC.33.1.128

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers.

Authors: L C Preheim; D Rimland; M J Bittner
Journal: Infect Control Date: 1987-05

2. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.

Authors: J E Dacre; A M Emmerson; E A Jenner
Journal: Lancet Date: 1983-10-29 Impact factor: 79.321

3. Rapid procedure for detection and isolation of large and small plasmids.

Authors: C I Kado; S T Liu
Journal: J Bacteriol Date: 1981-03 Impact factor: 3.490

4. Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.

Authors: M E Mulligan; P J Ruane; L Johnston; P Wong; J P Wheelock; K MacDonald; J F Reinhardt; C C Johnson; B Statner; I Blomquist
Journal: Am J Med Date: 1987-04-27 Impact factor: 4.965

5. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.

Authors: D P Levine; R D Cushing; J Jui; W J Brown
Journal: Ann Intern Med Date: 1982-09 Impact factor: 25.391

6. Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection.

Authors: R M Locksley; M L Cohen; T C Quinn; L S Tompkins; M B Coyle; J M Kirihara; G W Counts
Journal: Ann Intern Med Date: 1982-09 Impact factor: 25.391

7. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak.

Authors: L D Saravolatz; N Markowitz; L Arking; D Pohlod; E Fisher
Journal: Ann Intern Med Date: 1982-01 Impact factor: 25.391

8. The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.

Authors: S M Smith; R H Eng; E Berman
Journal: J Antimicrob Chemother Date: 1986-03 Impact factor: 5.790

9. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.

Authors: K E Aldridge; A Janney; C V Sanders
Journal: Antimicrob Agents Chemother Date: 1985-11 Impact factor: 5.191

10. Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital.

Authors: C M Bitar; C G Mayhall; V A Lamb; T J Bradshaw; A C Spadora; H P Dalton
Journal: Infect Control Date: 1987-01

32 in total

1. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.

Authors: J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal: Antimicrob Agents Chemother Date: 1997-08 Impact factor: 5.191

Review 2. Bacterial challenges and evolving antibacterial drug strategy.

Authors: B Watt; J G Collee
Journal: Postgrad Med J Date: 1992-01 Impact factor: 2.401

3. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.

Authors: M C Raviglione; J F Boyle; P Mariuz; A Pablos-Mendez; H Cortes; A Merlo
Journal: Antimicrob Agents Chemother Date: 1990-11 Impact factor: 5.191

4. Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.

Authors: S Sreedharan; L R Peterson; L M Fisher
Journal: Antimicrob Agents Chemother Date: 1991-10 Impact factor: 5.191

5. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.

Authors: H F Chambers; Q Xiang; L L Chow; C Hackbarth
Journal: Antimicrob Agents Chemother Date: 1999-11 Impact factor: 5.191

6. Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects.

Authors: E A Piercy; R E Bawdon; P A Mackowiak
Journal: Antimicrob Agents Chemother Date: 1989-09 Impact factor: 5.191

7. In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.

Authors: T Kojima; M Inoue; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191

8. In vitro activity of nadifloxacin against both methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus from patients with skin infections.

Authors: S Nishijima; S Namura; H Akamatsu; S Kawai; Y Asada; S Kawabata; M Fujita
Journal: Drugs Date: 1995 Impact factor: 9.546

9. In vitro activity of AT-4140 against clinical bacterial isolates.

Authors: T Kojima; M Inoue; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1989-11 Impact factor: 5.191

10. Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.

Authors: M P Weinstein; R G Deeter; K A Swanson; J S Gross
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191